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Activity of the four known protease-activated receptors (PARs) has been well studied in
rodent enteric nervous system and results in animal models established an important role
for neuronal PAR2. We recently demonstrated that, unlike in rodents, PAR1 is the dom-
inant neuronal protease receptor in the human submucous plexus. With this study we
investigated whether this also applies to the human myenteric plexus. We used voltage
sensitive dye recordings to detect action potential discharge in primary cultures of human
myenteric neurons in response to PAR activating peptides (APs). Application of the PAR1-
AP (TFLLR) or PAR4-AP (GYPGQV) evoked spike discharge in 79 or 23% of myenteric
neurons, respectively. The PAR1-AP response was mimicked by the endogenous PAR1
activator thrombin and blocked by the PAR1 antagonists SCH79797. Human myenteric
neurons did not respond to PAR2-AP. This was not due to culture conditions because all
three PAR-APs evoked action potentials in cultured guinea pig myenteric neurons. Consec-
utive application of PAR-APs revealed coexpression (relative to the population responding
to PAR-APs) of PAR1/PAR2 in 51%, PAR1/PAR4 in 43%, and of PAR2/PAR4 in 29% of
guinea pig myenteric neurons. Our study provided further evidence for the prominent role
of neuronal PAR1 in the human enteric nervous system.
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INTRODUCTION
Proteases are important for digestive degradation but are at the
same time signaling molecules in the gut (Vergnolle, 2005; Hollen-
berg, 2010). They initiate cellular responses through interactions
with four G-protein coupled protease-activated receptors (PARs;
PAR1-4; Vu et al., 1991; Nystedt et al., 1995; Ishihara et al., 1997;
Kahn et al., 1998; Xu et al., 1998). PARs are activated by spe-
cific proteolytic cleavage of their amino terminal extracellular
domain which then functions as a tethered ligand (Vergnolle,
2005). Endogenous PAR activators are serine proteases such as
thrombin which mainly activates PAR1 or the mast cell derived
tryptase which acts as a PAR2 activator. Actions of endogenous
proteases are mimicked by synthetic PAR activating peptides (PAR-
APs) which contain the amino acid sequence of the respective
tethered ligand. PAR-APs are available for PAR1, PAR2, and PAR4
(Corvera et al., 1999; Linden et al., 2001).
PARs are expressed on various cell types in the gut includ-
ing endothelial cells, epithelial cells, smooth muscle cells, immune
cells, and enteric neurons – both in the submucous and myenteric
plexus (Al Ani et al., 1995; Mari et al., 1996; Corvera et al., 1999;
Buresi et al., 2001; Cenac et al., 2002; Gao et al., 2002; Garrido et al.,
2002; Mall et al., 2002; Colognato et al., 2003; Kawabata et al., 2004;
Vergnolle, 2005; Li et al., 2008). Activation of PARs cause activation
of rodent enteric neurons as indicated by increased spike discharge
or increase in intracellular calcium level (Corvera et al., 1999; Lin-
den et al., 2001; Gao et al., 2002; Reed et al., 2003). More than 50%
of rodent myenteric neurons responded to PAR1 or PAR2 activa-
tors but only 25% to PAR4 activators (Corvera et al., 1999; Linden
et al., 2001; Gao et al., 2002).
There is strong evidence for involvement of PARs in func-
tional and inflammatory bowel diseases. In the stool of patients
with ulcerative colitis (UC) and irritable bowel syndrome (IBS)
increased concentrations of proteases were found (Bustos et al.,
1998; Cenac et al., 2007; Roka et al., 2007; Annahazi et al., 2009).
Additionally, mucosal biopsy supernatants from IBS patients con-
tained higher protease levels than supernatants from healthy con-
trols (Barbara et al., 2004; Buhner et al., 2009). One functional
consequence of the enhanced protease release has been demon-
strated in sensory and enteric neurons. Thus, supernatants taken
from colonic biopsy samples of IBS patients sensitized murine
sensory neurons and induced visceral and somatic hypersensitiv-
ity through activation of PAR2 (Barbara et al., 2007; Cenac et al.,
2007; Buhner et al., 2009). In addition, IBS supernatants evoked
spike discharge in human submucous neurons (Barbara et al.,
2007; Buhner et al., 2009). In both studies the unspecific serine
protease inhibitor FUT-175 inhibited neuronal responsiveness to
IBS supernatants.
Recently, we demonstrated that PAR1 rather than PAR2 or
PAR4 activators excited human submucous neurons (Mueller
et al., 2011). In this study we furthermore confirmed that PAR2
was indeed most prominent in the guinea pig submucous plexus.
Although the results suggested important species differences and
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plexus differences, it remained open whether the differential func-
tional PAR expression is also relevant in human myenteric neu-
rons. We therefore studied actions of PAR1, PAR2, and PAR4
activators in cultured human myenteric neurons and performed
comparative studies in cultured guinea pig myenteric neurons.
We have recently reported that recordings from cultured human
myenteric neurons more reliably reveal representative results than
from freshly dissected preparations (Vignali et al., 2010). Fur-
thermore we analyzed the PAR clustering in cultured guinea pig
myenteric neurons by pairwise application of PAR-APs.
MATERIALS AND METHODS
PRIMARY CULTURE OF HUMAN AND GUINEA PIG MYENTERIC
NEURONS
Human tissue samples from small (5) and large (21) intes-
tine were obtained from 26 patients [16 female and 10 male;
69.7± 2.2 years (mean± SEM)] undergoing surgery at the Med-
ical Clinics in Freising and Rechts der Isar in Munich. Samples
were taken from macroscopically unaffected areas. Diagnoses that
led to surgery were carcinoma (23), polyp (1), ileus (1), and
diverticulitis (1). Procedures were approved by the ethical com-
mittee of the Technische Universität München (1746/07; informed
consent was obtained from all subjects). After surgery, tissue
samples were placed in ice-cold oxygenated sterile Krebs solu-
tion and immediately transferred to our institute. Tissues were
dissected in ice-cold oxygenated sterile Krebs solution contain-
ing (in mM): 121 NaCl, 6 KCl, 12 Glucose, 14 NaHCO3, 1
NaH2PO4, 1 MgCl2·6H2O, 3 CaCl2·2H2O. These tissues were
dissected in order to obtain longitudinal muscle – myenteric
plexus (LMMP) preparations. Culture procedures were performed
after a previously described method to gain primary culture of
human myenteric neurons (Vignali et al., 2010). Similar prepa-
rations were done with guinea pig intestinal tissues. Briefly, male
guinea pigs (Dunkin Hartley, Harlan GmbH, Borchen, Germany)
were killed by cervical dislocation followed by exsanguination
(approved by the local animal ethical committee and accord-
ing to the German guidelines for animal protection and ani-
mal welfare). A 10 cm piece of the distal small intestine was
quickly removed. Further proceedings in human and guinea
pig were performed under sterile conditions. The sterile LMMP
preparations of both species were cut in ∼1 mm× 1 mm pieces
and digested for 20–70 min in an enzymatic solution contain-
ing 0.9 mg/mL protease type I from bovine pancreas (Sigma-
Aldrich, Steinheim, Germany), 1.2 mg/mL collagenase type II
from Clostridium histolyticum (Gibco, Karlsruhe, Germany) and
3.7 mg/mL bovine serum albumin fraction V (Serva, Heidelberg,
Germany). Enzymatic digestion was followed by washing steps
with ice-cold sterile Krebs solution. The obtained pellet was dis-
solved in medium M199 (Gibco). From this suspension ganglia
were picked under a stereomicroscope (Leica DMIL, 4× objec-
tives with phase contrast) and 2–5 dishes (Ibidi, Martinsried,
Germany) were inoculated with ganglia suspension. Myenteric
ganglia were incubated in medium M199 supplemented with
10% FBS (Gibco), 50–100 ng/mL mouse nerve growth factor 7S
(Alomone labs, Jerusalem, Israel), 5 mg/mL Glucose, 100 U/mL
Penicillin, 100µg/mL Streptomycin (Gibco), and 2µM arabinose-
C-furanoside (Sigma-Aldrich). The medium was changed every
2–3 days. At the first day after the culture the enteric neurons
adhere to the bottom of the dish. After 48–72 h the neurons tend
to reorganize themselves in structures defined as cluster that form
a network. The cultures were grown at least for 7 days before
performing an experiment.
For voltage sensitive dye recordings the dishes were placed in
a custom made recording chamber and continuously perfused
with 37˚C HEPES solution containing (in mM): 1 MgCl2·6H2O, 2
CaCl2·2H2O, 150 NaCl, 5 KCl, 10 Glucose, 10 HEPES.
MULTISITE OPTICAL RECORDING TECHNIQUE WITH VOLTAGE
SENSITIVE DYE
An ultrafast neuroimaging technique was used to record signals
from the fluorescent potentiometric dye 1-(3-sulfanato-propyl)-
4-[β-[2-(di-n-octylamino)-6-naphthyl] vinyl] pyridinium betaine
(Di-8-ANEPPS; Invitrogen, Darmstadt, Germany) as previously
described in detail (Neunlist et al., 1999; Schemann et al., 2002;
Michel et al., 2011). The cultured neurons were stained by incu-
bation with 500µL of 10µM Di-8-ANEPPS for 15 min at room
temperature in the dark.
The recording chamber was mounted onto an inverted epi-
fluorescence microscope (Zeiss Axio Observer.A1; Munich, Ger-
many). To detect the signals of Di-8-ANEPPS the microscope was
equipped with a modified Cy3 filterset (545± 15 nm excitation,
565 nm dichroic mirror, 580 nm barrier; Ahf Analysentechnik,
Tübingen, Germany) and excited by a green LED (LE T S2W,
Osram, Munich, Germany). We used the Neuroplex 9.1.1 software
(RedShirtImaging, Decatur, GA, USA) for acquisition and pro-
cessing of the signals. The changes of the membrane potential are
linearly related to the relative changes of the fluorescence (∆F/F)
which was measured by a cooled charge coupled device (CCD)
camera (80× 80 pixels, RedShirtImaging). Optical signals were
recorded with a frame rate of 1 kHz which enables the detection
of action potentials. With an x100 objective (NA= 1.35, Olympus,
Hamburg, Germany) the spatial resolution of the CCD camera is
∼4.0µm2 per pixel. The visualization of the outlines of the cells
marked by the dye that is incorporated in the cell membrane make
it possible to detect the signal of each single cell (Michel et al.,
2005).
DRUGS AND SOLUTIONS
Amino acid sequences that specifically activate the different PAR
receptors were used as PAR-APs. We used human specific PAR-
APs (PAR1-AP: TFLLR-NH2; PAR2-AP: SLIGKV-NH2; PAR4-AP:
GYPGQV-NH2) or rodent specific PAR-APs (PAR1-AP: SFFLR-
NH2; PAR2-AP: SLIGRL-NH2; PAR4-AP: GYPGKF-NH2). For
control experiments we used in human myenteric neurons also
the reversed peptide (RP) of PAR1 (PAR1-RP: RLLFT-NH2;
all from Peptide Synthesis Core Facility, University of Calgary,
Calgary, Alberta, Canada). 10 mM stock solutions of PAR-APs
and PAR1-RP were prepared with deionized water and stored
at −20˚C. Before experiments they were further diluted with
HEPES solution to 100µM. With human plasma derived throm-
bin (citrate-free; Merck KGaA, Darmstadt, Germany) a stock
solution at a concentration of 57.83µM diluted in deionized
water was prepared and stored at −80˚C. Final concentration
of 100 nM was obtained after dilution with HEPES solution.
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The PAR1 antagonist SCH79797 (N3-cyclopropyl-7-[[4-(1-
methylethyl)phenyl] methyl]-7H-pyrrolo[3,2-f]quinazoline-1,3-
diamine dihydrochloride; Biozol Diagnostica, Eching, Germany)
was dissolved in waterfree 100% dimethyl sulfoxide (Acros Organ-
ics, Geel, Belgium; Ahn et al., 2000). For experiments SCH79797
was added at a final concentration of 5µM for 20 min to the
superfusing HEPES solution. For all substances the pH was 7.4. To
identify neurons 100µM nicotine (Sigma-Aldrich) was applied
by pressure ejection from a glass pipette positioned about 500µm
away from the cell cluster. PAR1-AP, PAR2-AP, PAR4-AP, PAR1-
RP were also applied by pressure ejection at a concentration of
100µM, thrombin at a concentration of 100 nM. These substances
are diluted during pressure ejection by a factor of 1:5–1:10 before
reaching the cluster (Breunig et al., 2007). PAR-APs as well as
thrombin evoke a late onset neuronal response (Mueller et al.,
2011). We therefore adapted the microejection protocol as follows:
we applied the PAR activators for 2 s and recorded the response
of the neurons in four 2 s long trials; which were separated by
5–6 s intervals without recording. For analysis of PAR clustering
PAR-APs were applied pairwise in random order.
DATA ANALYSIS AND STATISTICS
The number of neurons responding to nicotine in the field of view
was counted and based on this number the percentage of neurons
responding to PAR activators per cluster was analyzed as well as the
spike discharge frequency. With the mean spike discharge of the
responding neurons per cluster multiplied with the percentage of
responding neurons in this cluster the neuroindex was calculated
and used for illustration of the results. As mentioned above, PAR
activators evoke a late onset spike discharge (Mueller et al., 2011).
We therefore analyzed spike discharge frequency during the last
three trials as there were rarely spikes during the first acquisition.
PARs desensitize to repeated application of activators (Gao et al.,
2002). We therefore studied blockade of PAR1 by SCH79797 by
comparing PAR1-AP effects before and during perfusion of the
PAR1 antagonist in two different clusters obtained from the same
patient. We analyzed the voltage sensitive dye signals with Neuro-
plex 8.3.2 (RedShirtImaging), Igor Pro 6.12A (Wavemetrics Inc.,
Lake Oswego, OR, USA) and SigmaPlot 12 (Systat Software Inc.,
Erkrath, Germany). Since all data were not normally distributed
they are presented in the text as median with their 25 and 75%
quartiles. Differences of responses were tested with Rank Sum
Test. Multiple comparisons were performed with Kruskal–Wallis
one-way analysis of variance (ANOVA) on ranks. Differences were
considered significant when p< 0.05. For readability the numbers
of patients, clusters, and neurons are all presented in the figure
legend and only mentioned in the text if not graphically illustrated.
RESULTS
PAR1-AP induced a considerable spike discharge in human myen-
teric neurons, whereas PAR4-AP or PAR2-AP evoked significantly
less or no spike discharge, respectively (Figures 1 and 2). The neu-
roindex in Figure 2 is a product from the proportion of responding
neurons per cluster and the PAR activator evoked mean spike
discharge. PAR1-AP application evoked spike discharge in 79%
(44 of 56 neurons) of the neurons at a median frequency of 1.5
(0.9/3.5) Hz. PAR2-AP failed to activate any human myenteric
neurons (0 of 20 neurons). To PAR4-AP application only 23% (7
of 31 neurons) of myenteric neurons fired at a median frequency
of 0.3 (0.2/0.5) Hz. PAR1-AP application activated significantly
more neurons and evoked a significantly higher spike discharge
(p≤ 0.001; Figure 2).
The response to PAR1-AP was specific as application of PAR1-
RP had no effect (seven neurons from four clusters and two
patients). In addition, the PAR1 specific antagonist SCH79797
(5µM) fully abolished the response to PAR1-AP (Figure 2). While
control applications of PAR1-AP evoked a response in 85% (11 of
13 neurons) of neurons, application of PAR1-AP in the presence
of SCH79797 evoked no action potentials in any neuron (0 of 18
neurons; p≤ 0.001).
In rodent myenteric neurons PAR2 activation evoked a reliable
activation (Corvera et al., 1999; Linden et al., 2001; Gao et al.,
2002). We wanted to exclude that our culture conditions would
negatively influence PAR2 activation. We therefore studied the
effects of rodent specific PAR1-AP, PAR2-AP, and PAR4-AP on
guinea pig primary cultured myenteric neurons. PAR1-AP acti-
vated 42% (61 of 145 neurons) of guinea pig myenteric neurons
with a median spike discharge of 1.0 (0.3/2.7) Hz. PAR2-AP evoked
a similar activation of neurons and induced a median spike dis-
charge of 0.5 (0.3/1.7) Hz in 43% (71 of 165 neurons) of myenteric
neurons. PAR4-AP activated 22% (38 of 170 neurons) of myenteric
neurons with a median spike discharge of 0.3 (0.2/0.9) Hz.
In order to determine clustering of PAR in guinea pig myen-
teric neuron cultures we pairwise applied PAR-APs. Applications
of PAR1-AP and PAR2-AP revealed that 51% of the neurons (31
out of 61) responded to both, 34% (21 out of 61) to PAR1-AP
only, and 15% (9 out of 61) to PAR2-AP only. Similar experiments
with PAR1-AP and PAR4 AP showed that 43% of the neurons (20
out of 46) responded to both, whereas 39% (18 of 46) to PAR1-
AP only and 17% (8 out of 46) to PAR4-AP only. Applications of
PAR2-AP and PAR4-AP revealed that 29% of neurons (24 out of
84) responded to both, 46% (39 out of 84) to PAR2-AP only, and
25% (21 of 84) to PAR4-AP only (Figure 3).
PAR1-AP by far evoked the strongest activation in human
myenteric neurons. The endogenous PAR1 activator thrombin
evoked in 26% (16 of 61 neurons) of human myenteric neurons
a median spike discharge of 1.3 (0.8/2.5) Hz (Figures 1 and 2).
Thus PAR1-AP activated significantly more neurons than throm-
bin (p≤ 0.001). This was due to the relatively high proportion of
clusters in which no neurons responded to thrombin. This was the
case in 71% of the clusters; in the remaining 29% thrombin acti-
vated as many neurons as the PAR1-AP [56% (28 of 50 neurons)
vs. 79% (44 of 56 neurons)]. Thrombin furthermore induced a
similar spike discharge as PAR1-AP in these neurons [1.3 (0.8/2.5)
vs. 1.5 (0.9/3.5) Hz]. In guinea pig cultured myenteric neurons
40% (8 of 20 neurons) were activated by thrombin with a spike
discharge of 0.5 (0.4/2.5) Hz.
DISCUSSION
The results of our study provided further support for the dom-
inant role of PAR1 in the human enteric nervous system. We
found that both the PAR1-AP as well as the endogenous acti-
vator thrombin excited human myenteric neurons. In contrast,
PAR4-AP evoked less activation while PAR2-AP had no effect. The
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FIGURE 1 | PAR-APs and thrombin activate cultured myenteric neurons.
Representative traces of voltage sensitive dye recordings showing neuronal
responses to a 2 s spritz application (indicated by the horizontal gray bar) of
PAR1-AP, PAR2-AP, PAR4-AP, and thrombin. Recordings were made in four 2 s
long recording periods with 5–6 s intervals in between (indicated by the
symbol between the traces). Every peak represents an action potential. (A)
Representative traces from cultured human myenteric neurons to human
specific PAR-APs and thrombin show comparable responses to PAR1-AP and
thrombin but no response to PAR2-AP and a minor response to PAR4-AP. (B)
Guinea pig cultured myenteric neurons fire action potentials in response to
PAR1-AP, PAR2-AP, PAR4-AP, and thrombin; the PAR4 response is rather
moderate.
failure of PAR2-AP to evoke spike discharge was not due to cul-
ture conditions as PAR2 activation readily evoked spike discharge
in cultured guinea pig myenteric neurons. These findings expand
on our previous observation that PAR1 rather than PAR2 activa-
tors induce neuronal activation in the human submucous plexus
(Mueller et al., 2011). We thereby demonstrated that PAR2 played
a minor role in both the submucous and myenteric plexus whereas
neuronal PAR1 dominated in both plexi of the human enteric ner-
vous system. These differences between human and rodent enteric
neurons must be considered when translating findings on involve-
ment of PARs from animal models to human gut pathology. The
physiological relevance of this striking species difference remains
to be explored.
In guinea pig cultured myenteric neurons PAR1-AP, PAR2-
AP, and thrombin evoked similar responses, whereas less neu-
rons responded to PAR4-AP. This finding agrees with data in
non-dispersed (Linden et al., 2001; Gao et al., 2002) and dis-
persed myenteric plexus neurons (Corvera et al., 1999). We found
evidence for a functional PAR clustering in cultured myenteric
neurons. Our study revealed that 51% responded to PAR1 and
PAR2, a value that is almost identical to the ∼60% reported from
a similar study in dispersed myenteric neurons (Corvera et al.,
1999). In addition, we provided first data on clustering of PAR1
with PAR4 (43%) and PAR2 with PAR4 (29%).
We found that 79% of human myenteric neurons fired action
potentials in response to PAR1-AP. This proportion is very sim-
ilar to the PAR1-AP responsive neurons in the human submu-
cous plexus (71%, Mueller et al., 2011). In addition the endoge-
nous PAR1 activator thrombin evoked spike discharge in 26% of
human myenteric neurons. In our experiments in cultured human
myenteric neurons much less neurons responded to thrombin
in comparison to the PAR1-AP. In freshly dissected guinea pig
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FIGURE 2 | Analysis of neural actions of PAR-APs and thrombin in
cultured human and guinea pig myenteric neurons.The graphs
represent (from top to bottom) the proportion of neurons per cluster
responding to a specific PAR activator, the specific PAR activator evoked
spike frequency and the neuroindex which is the product of spike
frequency and proportion of responding neurons. Data are illustrated with
scatter plots showing the 25%/75% and the bars indicating the 10%/90%
percentiles. PAR1-AP induced the strongest effect in human myenteric
neurons, whereas PAR4-AP evoked only weak responses and PAR2-AP no
response. Thrombin also activated human myenteric neurons but to a
lesser degree than PAR1-AP. The PAR1-AP effect in human neurons is
blocked by the specific PAR1 antagonist SCH79797. In guinea pig
myenteric neurons the responsiveness to PAR1-AP, PAR2-AP, and thrombin
was similar, but PAR4-AP evoked a spike discharge in less neurons at a
significantly lower frequency. *Indicates significant differences to PAR1-AP
in human neurons; # indicates significant differences to PAR1-AP in guinea
pig neurons. Numbers in parenthesis indicate numbers of
tissue/clusters/neurons.
preparations the neuronal responsiveness to thrombin and PAR1-
AP was quite similar (Corvera et al., 1999; Hollenberg and Comp-
ton, 2002). One possible explanation could be differences in
potency although thrombin appears to have a higher potency
than the PAR1-AP (Corvera et al., 1999; Hollenberg and Comp-
ton, 2002). Another reason may be the culture conditions which
require the use of proteases for tissue digestion. During the cul-
ture period the neurons may be exposed to unspecified proteases
present in the supplemented serum. We cannot exclude that some
of these proteases may inactivate or disarm PAR1, which has been
described for cathepsin G, plasmin, elastase, proteinase-3, and
trypsin (Ossovskaya and Bunnett, 2004; Hollenberg et al., 2008;
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FIGURE 3 | Response pattern to PAR-APs in guinea pig cultured
myenteric neurons demonstrates receptor clustering. (A) Image shows
outlines of a cluster of guinea pig cultured myenteric neurons stained with
the voltage sensitive dye Di-8-ANEPPS. (B) Representative traces of a neuron
[marked with a star in (A)] that responded to PAR1-AP and PAR2-AP (2 s spritz
application indicated by a gray horizontal bar). Recordings were made in four
2 s long recording periods with 5–6 s intervals in between (indicated by the
symbol between the traces). Every peak represents an action potential. (C)
Pairwise application of PAR-APs revealed functional coexpression patterns.
Proportions of neurons responding to two PAR-APs are expressed relative to
the proportion of neurons responding to any PAR-AP in that particular set of
experiment (100%).
Ramachandran et al., 2012). In the disarmed state the PAR1 can be
still activated by the tethered ligand, but not by thrombin. Irrespec-
tive of whether culture conditions may affect PAR1 activation by
thrombin,our results clearly demonstrated that thrombin activates
human myenteric neurons.
Strikingly, while PAR2-AP activated at least a small population
of human submucous neurons (6.3%) it did not evoke spikes in
any human myenteric neurons. This may be a reflection of the
pronounced gradient of mast cells, which release tryptase as the
main endogenous PAR2 activator, in the human gut wall (Buhner
and Schemann, 2012). While there was a close anatomical asso-
ciation between mast cells and nerves in the submucous layer,
there were hardly any mast cells in the human myenteric layer. We
may exclude that the dispersal procedures or receptor internaliza-
tion interfered with PAR2 activation in human cultured neurons
for several reasons. Firstly, identical culture conditions did not
negatively affect PAR2 activation in guinea pig myenteric neuron
culture. Secondly, inability to record PAR responses due to recep-
tor internalization would be expected to affect all PARs; but we
readily evoked responses to PAR1-AP and PAR4-AP in cultured
human myenteric neurons. We are not aware of data suggesting
that inactivation of PAR2 by internalization is more pronounced
than for PAR1 or PAR4.
Our results do not rule out involvement of non-neuronal
PAR2 in the regulation of gastrointestinal functions in humans.
PAR2 are functionally expressed on epithelial cells, myofibrob-
lasts, smooth muscle cells, and PAR2 activation does evoke
direct responses in these cells (Seymour et al., 2005; Sato et al.,
2006; Kawabata et al., 2008; Tanaka et al., 2008; Mueller et al.,
2011).
PAR1 activation modulates motility and visceral sensitivity in
several animal models (Kawabata et al., 2008). Whether this also
applies to human intestine is not known. However, clinical trials
with PAR1 antagonists as anti-platelet medication reported as side
effects in a small number of patients nausea, constipation or vis-
ceral pain although their incidence was not significantly higher
than for the placebo group (O’Donoghue et al., 2011; Shinohara
et al., 2012).
In conclusion, our data provide further evidence for the promi-
nent role of neuronal PAR1 in the human enteric nervous system
and suggest their prominent involvement in muscle and epithelial
functions.
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